Table:
begin	end	state
1	20	cytoplasmic
21	39	transmembrane
40	42	non-cytoplasmic
43	66	transmembrane
67	101	cytoplasmic
102	124	transmembrane
125	129	non-cytoplasmic
130	152	transmembrane
153	159	cytoplasmic
160	183	transmembrane
184	204	non-cytoplasmic
205	227	transmembrane
228	247	cytoplasmic
248	269	transmembrane
270	280	non-cytoplasmic
281	305	transmembrane
306	339	cytoplasmic
340	360	transmembrane
361	365	non-cytoplasmic
366	392	transmembrane
393	411	cytoplasmic
412	430	transmembrane
431	435	non-cytoplasmic
436	454	transmembrane
455	471	cytoplasmic

Input:
>AO353_25190
MKSTPSERVEQPALQRTLSNRHIQLMAMGGAIGTGLFMGSGKIIALSGTSIILIYMIIGM
FVYFVMRAMGELLLSNLNFKTFADFTGAYLGPRAAFFLGWSYWLSWSVAVVGDAVVVGGF
FQYWFPDVPAWIPAVGMLMTLFALNVLTVRLFGEVEFWFAIIKIIAVVTLIGVSLVMIAS
SFVSPSGVTASLNHLLDKQAAFPNGLFGFFAGFQMAIFSFAGTELIGTAAAETRSPEKTL
PKAINSIPLRIILFYVLALACIIAVTSWQQVSPNKSPFVELFLVAGFPAAAGIVNFVVLT
SAASSANSGVFSSSRMLFGLASHDNAPGIFRHLSRNSVPLLSLAFTTLLMLVGVLLLFIV
PEVMTAFTIVSTVSAILVIFTWSTILASYIAYRKSRPDLHAKSVYKMPGGVPMAWFSLTF
LGFVLCLLALRPDTRIALLVMPGWFIWLAIAYQLTHSRKLRSAAGSANQYS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server